COMETRIQ
Active substance: cabozantinib
KIT · cabozantinib
United StatesActive
Marketing holder: Exelixis, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
Analogues by country
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-1693-78ef-b925-aacf70e23b50,01a12093-66e2-7eb3-b657-c1f770a1f7a2;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 42388-012
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 42388-012 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42388-012 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42388-012 · Verified 2026-10-09 · open in source